Holen Sie sich die Stockscreener-App
0.7098
1.68%
-0.00
Handel nachbörslich:
.71
0.0002
+0.03%
Mustang Bio Inc Aktie (MBIO) Neueste Nachrichten
TDW Q1 2026 Earnings: Significant EPS Miss Despite Stock GainDebt Analysis Report - dars.gov.et
MSN Money - MSN
Enterprise value to EBIT forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Enterprise value to EBITDA forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Enterprise value to EBIT forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Price to book forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to earnings forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Enterprise value to revenue forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to sales forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Price to sales forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Traders are paying attention to the gapping stocks in Friday's session. - ChartMill
Mustang Bio Inc (MBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mustang Bio, Inc. Actuals & Estimates (NASDAQ:MBIO) - TradingView
Silver Tiger Metals Inc.'s (TSE:SLVR) Path To Profitability - simplywall.st
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Significant EPS Miss Reflects Ongoing Clinical-Stage Challenges - dars.gov.et
Glioma Pipeline Insights Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
MBIO Should I Buy - Intellectia AI
Mustang Bio Inc (MBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mustang Bio Inc (MBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mustang Bio Inc (MBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mustang Bio Inc (MBIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mustang Bio Inc (MBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mustang Bio Inc (MBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mustang Bio Inc (MBIO) Institutional Confidence - TradingKey
Mustang Bio Inc (MBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SpaceX IPO Leaves Retail Investors Scrambling as Tiny Allocations Spur Mixed ReactionsBuyback Announcement Report - newsline.com
CNET Q3 2011 Earnings: EPS Misses by 65.4% Amid Uncertain Revenue DisclosureEarnings Growth Analysis - newsline.com
Getty Images Holdings (GETY) Slides 2.55% as Stock Nears Key Support at $0.70VWAP Breakout - newsline.com
MBIO Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: EPS Misses by Wide Margin Amid No Revenue; Stock DeclinesEstimate Uncertainty - Město Břeclav
ADXN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CCL Q1 2026 Earnings: EPS Surpasses Estimates by 7.3%, Shares Gain 2.5%Cash Flow Report - newsline.com
Spring Valley Acquisition Corp. III (SVAC) Holds Near Support Amid Modest DeclineRTH Profile - newsline.com
Mustang Bio (MBIO) Moves Higher, Testing Key Resistance at $0.83Analyst Downgrade Signals - newsline.com
Water Utility Fined £1.8 Million Over Parasite Outbreak in DevonProfit Announcement - newsline.com
JATT Price Today: JATT II Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Mustang Bio Q4 2024 Earnings: Massive EPS Miss Highlights Cash Burn and Clinical Progress UncertaintyCFO Commentary Report - newsline.com
Mustang Bio (MBIO) Q4 2024 Earnings: Wider-Than-Expected Losses Offset by Positive Stock Movement Amid Pipeline FocusGuidance Accuracy Score - newsline.com
WaFd Inc. (WAFD) Q1 2026 Earnings: EPS Tops Estimates; Small Decline in StockFree Cash Flow Trends - The Legal Advocate
Real Asset Acquisition Corp. Unit (RAAQU) Holds Steady Near Support as Consolidation Phase ContinuesInvestment Factor - The Legal Advocate
Is Mustang Bio (MBIO) a Hidden Gem in the Microbiome Revolution, or a Risky Bet - Kavout
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Wider-than-Expected Loss Amid Pre-Revenue StageEarnings Miss Alert - newsline.com
Mustang Bio Inc. (MBIO) Gains 5.68% as Shares Approach Key Resistance at $0.70Merger Arbitrage - The Legal Advocate
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Severe EPS Miss Highlights Pre-Revenue Biotech Challenges - The Legal Advocate
Camtek (CAMT) Pulls Back 2.9% as Shares Test Key Support Zone Near $161SMA Signal - dars.gov.et
MBIOMustang Bio Inc Stock Price and Quote - Finviz
Varonis Systems (VRNS) Holds Steady Amid Minor Dip; Key Levels in FocusHull Moving Average - The Legal Advocate
SKYX Platforms Stock Slides: Support Test at $1.05 as Bearish Pressure MountsIV Rank - newsline.com
OSBC Q1 2026 Earnings: Earnings Miss Estimates Amid Narrowing MarginsTrough Earnings Signal - newsline.com
Universal Corporation (UVV) Q1 2026 Results Miss Estimates — EPS $1.32 vs $1.94Weak Earnings Momentum - The Legal Advocate
Mustang Bio (MBIO) Slides -1.27% as Selling Pressure Mounts 2026-05-18AI Expert Picks - Newser
What Mustang Bio (MBIO)'s -0.88% Decline Means for Investors 2026-05-18Stock Analysis Community - Newser
Mustang Bio stock (US62815P1003): restructuring progress keeps spotlight on cash and pipeline - AD HOC NEWS
Mustang Bio stock (US62815P1003): restructuring moves and Nasdaq relisting plan put focus back on ce - AD HOC NEWS
Brigade Enterprises FY26 Pre-Sales Dip 5% to Rs 7,424 Crore on Approval Delays; Board Recommends 1:3 Bonus IssueEarnings Outlook Update - The Legal Advocate
Mustang Bio’s Cancer Therapy Bets Face A Nasdaq Countdown - Finimize
TradingKey - TradingKey
0.86%
3.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):